GLSI
Greenwich LifeSciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$18.99
+3.26%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 4.70x
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 89.43x
- Price / sales
- —
- Price / cash flow
- -22.32x
Enterprise value
- Enterprise value
- $269.9M
- EV / sales
- —
- EV / EBITDA
- -12.45x
- EV / EBIT
- -12.34x
- Market cap
- $278.7M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026